International Prognostic Index (IPI), Prognosis in Aggressive Non-Hodgkin's Lymphoma

Purpose: To estimate the prognosis for a patient with aggressive non-Hodgkin's malignant lymphoma based on clinical findings.

Info MyLikes MyPaths

Evaluation

Age of patient

years

Stage of lymphoma by the Ann Arbor classification

Number of extranodal sites of involvement

Serum LDH

Upper limit of reference range for LDH

Is the patient symptomatic?

Yes

Is the patient fully ambulatory?

Yes

Percent of daytime patient spends in bed, enter from 0 to 100

percent

Is the patient bedridden and in need of assistance with the activities of daily living?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

ECOG performance status

International Index

• risk group

• complete remission

• 5 year relapse free

• 5 year survival

Age-adjusted International Index

• risk group

• complete remission

• 5 year relapse free

• 5 year survival

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Severity, Prognosis, Stage

Therapy

Selection
- Prognostic Factors for AIDS-Associated Primary Effusion Lymphoma (PEL)

Monitoring

Response To Therapy
- Response Criteria for Therapy in Non Hodgkin's Lymphoma

Specialty

Hematology Oncology

Objective

criteria for diagnosis
severity
prognosis
stage
options
response to therapy

ICD-10

C85 - Other and unspecified types of non-Hodgkin lymphoma

Info

Purpose: To estimate the prognosis for a patient with aggressive non-Hodgkin's malignant lymphoma based on clinical findings.

Specialty: Hematology Oncology

Objective: criteria for diagnosis, severity, prognosis, stage, options, response to therapy

ICD-10: C85,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path